Case Report on Tocilizumab Bridging Therapy for Liposarcoma Surgery

A single clinical case report documents a 56-year-old male with recurrent retroperitoneal dedifferentiated liposarcoma complicated by a severe cytokine release syndrome. The report details the patient's hematological parameters, treatment with tocilizumab and methylprednisolone, and subsequent surgical outcomes. Jinjin Li authored the report, which was last updated on figshare in May 2026.

Use Cases

• Analyze cytokine release syndrome manifestations based on clinical features like leukocytosis, anemia, and thrombocytopenia.
• Study interleukin-6 pathway blockade efficacy based on the documented use of tocilizumab.
• Investigate surgical timing challenges based on the case's description of cytopenias complicating management.

Strengths

• The report provides specific hematological values, including white blood cell count (43×10⁹/L), hemoglobin (30 g/L), and platelet count (10×10⁹/L).
• It details a complete clinical timeline from diagnosis through treatment and follow-up.
• The document is licensed under CC-BY-4.0, permitting open reuse.

Limitations

• The dataset is a single case report (22.3 KB), offering limited scope for statistical analysis.
• Column-level documentation is absent; field semantics must be inferred from the narrative text.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Clinical case documentation.

Freshness

Last updated 2026-05-05 04:12:54; freshness should be verified.